MedTrace Logo

Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer

NCT01569282 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-03-22

No results posted yet for this study

Summary

Double bypass (hepaticojejunostomy + gastrojejunostomy) is compared to stent strategy in patients planned for curative pancreatic resection in whom peroperative findings makes resection impossible.

Conditions

Interventions

PROCEDURE

Hepaticojejunostomy and gastroenterostomy

Standard surgical techniques

PROCEDURE

Stent strategy

Biliary and/or enteral stents on demand

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Principal Investigators

  • Lars Fändriks, Professor · Göteborg University

  • Claes Jönsson, Ass. Prof. · Gothenburg Universitity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-04-30
Completion
2015-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569282 on ClinicalTrials.gov